Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990-1995. Clinical Therapeutics 20(4): 871-84; 870, 1998
Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: An assessment of office-based visits in the United States, 1992-1997. Clinical Therapeutics 22(12): 1575-1589, December, 2000
Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992-1997. Clinical Therapeutics 22(12): 1575-1589, 2001
Trend in the Use of Antidepressant Pharmacotherapy and Diagnosis of Depression in the US. Cns Drugs 14(6): 473-481, 2000
Anxiety disorders in the USA, 1990 to 1997: Trend in complaint, diagnosis, use of pharmacotherapy and diagnosis of comorbid depression. Clinical Drug Investigation 20(4): 255-265, October, 2000
What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. International Journal of Psychiatry in Medicine 28(4): 407-419, 1999
What Factors Influence the Prescribing of Antidepressant Pharmacotherapy? An Assessment of National Office-Based Encounters. International Journal of Psychiatry in Medicine 28(4): 407-419, 1998
Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits. American Journal of Cardiovascular Drugs, 2017
Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. International Journal of Dermatology 43(1): 6-11, 2004
Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. International Journal of Dermatology 43(1): 6-11, 2003
Diagnosis of depression and use of antidepressant pharmacotherapy among adults in the United States: does a disparity persist by ethnicity/race?. Clinical Drug Investigation 32(2): 139-144, 2012
Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemia. American Journal of Cardiovascular Drugs 10(2): 105-108, 2010
Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Archives of General Psychiatry 67(12): 1256-1264, 2011
Characteristics of office-based physician visits for cutaneous fungal infections. an analysis of 1990 to 1994 National Ambulatory Medical Care Survey Data. Cutis 69(3): 191-8, 201-2, 2002
Assessment of the incidence of psoriasis based on data from office visits and medical examinations. Vestnik Dermatologii i Venerologii: 46-48, 1985